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Teriparatide is the active fragment (1–34) of the endogenous human parathyroid 
hormone (PTH). Studies showed that chronic administration of PTH results in decreased 
bone mass while intermittent exposure to PTH activates osteoblast bone deposition. 
Most of the structural studies published so far about the effect of Teriparatide focused 
their attention on the amount of newly-deposed bone without investigating the quality of 
the newly-formed bone tissue; moreover, most of the papers enhance the attention to the 
osteoblast’s cellular and molecular involvement during the process of bone repair, 
ignoring the pivotal role that osteocytes play in the bone environment by means of the 
modulation of their signaling. During bone regeneration, after a preliminary formation of 
fibrous tissue with massive vascular proliferation, two different types of osteogenesis 
follow each other: firstly the process of Static Osteogenesis, which produces preliminary 
bony trabeculae with woven texture and, later, the process of Dynamic Osteogenesis, in 
which osteoblasts, driven by osteocytes, produce a more ordered and more mechanical 
valid bone. This work includes both in vivo and in vitro investigations: i) in 
vivo morphological analyses of qualitative repair of experimentally induced lesions in 
diaphysis of rats femurs and ii) in vitro study of the osteocyte cell-signaling, both in 
response to Teriparatide treatment, in order to deepen the knowledge of morphological 
and molecular events occurring in bone regeneration, with particular attention to the 
osteocyte signaling. The results obtained showed that the intermittent administration of 
Teriparatide in vivo anticipates the beginning of Dynamic Osteogenesis, which is 
characterized by the production of a more ordered and resistant bone. The molecular 
biology data, performed on an osteocyte immortalized cellular model (MLO-Y4) 
treated in vitro with the drug at different time points showed, by microarray and western 
blot analysis, different gene/protein expression involved in osteocyte signaling compared 
with the control condition. 
 
